DOI:
10.1055/s-00034914
Osteologie
LinksClose Window
References
Freemantle N, Satram-Hoang S, Tang ET. et al.
Final results of the DAPS (Denosumab Adherence Preference Satisfaction) study: a
24-month, randomized, crossover comparison with alendronate in postmenopausal
women.
Osteoporos Int 2012;
23 (01) 317-326
We do not assume any responsibility for the contents of the web pages of other providers.